RNS Number:1919Z
Dexion Alpha Strategies Limited
28 June 2007

Dexion Alpha Strategies Limited (the "Company")

Estimated Net Asset Values

Ordinary Shares

As at the close of business on 22nd June 2007, the estimated net asset values of
the Company's shares are as follows:-
   Share Class            NAV          WTD Performance     MTD Performance     YTD Performance
     # Shares         107.32pence          +0.49%              +0.92%              +6.95%
    EUR Shares        EUR 1.5252           +0.47%              +0.94%              +6.39%
    US$ Shares        US$ 1.8924           +0.50%              +0.92%              +7.00%

These valuations, which have been prepared in good faith by the Company's
investment manager, are for information purposes only and are based on the
unaudited estimated valuations supplied to the Company's investment adviser by
the administrators or managers of the Company's underlying investments. Such
estimates may be subject to little verification or other due diligence and may
not comply with generally accepted accounting practices or other generally
accepted valuation principles. In addition, some of those estimates may not be
supplied on a regular or timely basis with the result that the values of such
investments are based on the latest available estimates which may be some time
before the date set out above. In respect of the valuations, 5 of the Company's
69 investments have not been valued within 7 days of such date. Other risk
factors which may be relevant to these valuations are set out in the Company's
prospectus dated 10 March 2006.

Investment Policy

The Company will seek to achieve its investment objective through investment in
an actively managed portfolio of underlying funds diversified across a range of
alternative investment strategies which target emerging and/or under-exploited
sources of alpha. The Company does not invest in other UK listed investment
companies (including UK listed investment trusts).



Voting Rights and Capital



Following the announcement of 27th June 2007 where the Company purchased a
further 500,000 of its Euro shares to be held in treasury the Company's capital
consists of 90,142,343 # Shares (excluding treasury shares), 7,252,548 US$
Shares (excluding treasury shares) and 31,333,467 Euro Shares (excluding treasury
shares) with voting rights. Therefore, the total number of voting rights in the
Company is 90,142,343 in respect of the # Shares, 7,252,548 in respect of the
US$ Shares and 31,333,467 in respect of the Euro Shares.



All Shareholders have equal voting rights based on the number of Shares held.
Accordingly, the total number of voting rights in the Company is 128,728,358 and
this figure may be used by Shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in the Company under the FSA's Disclosure and
Transparency Rules.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NAVIIFETRVITFID

Dexion Alpha Strategies (LSE:DASL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024 Dexion Alpha Strategies 차트를 더 보려면 여기를 클릭.
Dexion Alpha Strategies (LSE:DASL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024 Dexion Alpha Strategies 차트를 더 보려면 여기를 클릭.